Index Management Solutions’s PDL BioPharma, Inc. PDLI Stock Holding History

Index Management Solutions’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-38,850	Closed	-$290K	–	1164
2014 Q3	$290K	Buy	38,850 +11,698	+43%	+$109K	0.03%	469
2014 Q2	$263K	Buy	27,152 +18,596	+217%	+$166K	0.03%	492
2014 Q1	$71K	Buy	+8,556	New	+$73.3K	0.01%	604

Other funds holding PDLI

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Index Management Solutions's PDLI Position: Q4 2014 in Review

Index Management Solutions sold out of PDL BioPharma, Inc. (PDLI) in Q4 2014, closing a stake of 38,850 shares — an estimated $290K sold.

Index Management Solutions first reported a position in PDLI in Q1 2014 and held it in 3 quarters. The position peaked at $290K in Q3 2014. 223 funds tracked by Wall St. Rank hold PDLI as of Q4 2014.

Index Management Solutions reported no remaining PDL BioPharma, Inc. position as of Q4 2014 after selling out during the quarter.
Index Management Solutions sold 38,850 PDL BioPharma, Inc. shares in Q4 2014, an estimated $290K.
Index Management Solutions first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 3 quarters.
Index Management Solutions's PDL BioPharma, Inc. position peaked at $290K in Q3 2014.
223 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2014.

Based on Index Management Solutions's 13F filing for Q4 2014, filed 13 Feb 2015.